“ A case of cyclophosphamide-induced posterior reversible encephalopathy syndrome: Is it dose-related side effect?”, Yemen J Med, vol. 1, no. 2, pp. 103–107, Nov. 2022, doi: 10.32677/yjm.v1i2.3684.